Specialties

Meta-analysis examines the effectiveness of interventions in improving and preventing diabetes depression.

According to more than 200 studies involving 1.4 million patients, metformin reduces heart disease risk in diabetes patients more effectively than its competitors.

This is the fourth drug to treat diabetes that also can reduce the risk of heart disease.

A secondary analysis of the TECOS trial affirms sitagliptin does not increase heart failure risk for patients with type 2 diabetes.

According to a new study, one more disease is associated with diabetes: twin study suggests genetic link between obesity, psoriasis and diabetes.

Study shows effect low levels of the hormone have on blood glucose.

Insulin may not be the culprit in poorer outcomes, according to TUXEDO sub-study.

Female, 57 years of age, type 2 diabetes, metformin 1,000mg twice daily for 12 years, came in with weakness, anemia, tingling of fingers and toes. Her A1C had always been below 7%. Some in my office thought she had developed diabetic peripheral neuropathy. I could not disagree, but I also knew metformin can cause vitamin B12 deficiency.

Researchers saw long-term reduction in end-stage renal disease, without evidence of increased risk for cardiovascular events or death.

New meta analysis suggests overly aggressive goals may increase cardio risk for patients with systolic blood pressure below 140 mm Hg.